TrialNature communications2026
Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial.
Roxane Riemer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.